3.51 USD
▲+0.05+0.57%
盘后 3.43 -1.72%
2026-08-03
市值
$14.89M
市盈率
—
EPS
-1.47
股息率
—
52 周区间
1.03 – 8.48
成交量
6.37K
Beta
1.75
目标价
—
52W 低 1.0352W 高 8.48
价格走势
公司简介
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufa...